Drugs that retard estrogen competence reduce women’s risk of breast cancer for 10 years, according to a new examination of studies. Postmenopausal women in a studies who took drugs called resourceful estrogen receptor modulators (SERMs), such as tamoxifen, were 38 percent rebate expected to rise any form of breast cancer over a 10-year period, compared [...]
↧